![PRD_002267 PRD_002267](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002267.svg) | PRD_002267 | Name: | D-Arg4,Leu10-Teixobactin | Formula: | C59 H101 N14 O14 | Definition date: | 2020-08-19 | Last modified: | 2020-08-19 |
|
![PRD_002268 PRD_002268](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002268.svg) | PRD_002268 | Name: | Lipid II | Formula: | C54 H91 N8 O26 P2 | Definition date: | 2020-08-19 | Last modified: | 2023-06-11 |
|
![PRD_000185 PRD_000185](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000185.svg) | PRD_000185 | Name: | SURFACTIN nC15 | Formula: | C52 H91 N7 O13 | Definition date: | 2020-08-12 | Last modified: | 2023-09-20 |
|
![PRD_000561 PRD_000561](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000561.svg) | PRD_000561 | Name: | FR901277 | Formula: | C47 H63 N9 O13 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
![PRD_002187 PRD_002187](https://data.pdbj.org/pdbjplus/data/cc/svg/V66.svg) | PRD_002187 | Name: | tert-butyl [(4S,7S,10S)-7-(cyclohexylmethyl)-10-(hydroxymethyl)-5,8,13-trioxo-23-oxa-6,9,14,21,22-pentaazabicyclo[18.2.1]tricosa-1(22),20-dien-4-yl]carbamate | Formula: | C30 H50 N6 O7 | Definition date: | 2020-08-12 | Last modified: | 2020-08-12 |
|
![PRD_002189 PRD_002189](https://data.pdbj.org/pdbjplus/data/cc/svg/V64.svg) | PRD_002189 | Name: | tert-butyl [(4S,7S,10S)-7-(cyclohexylmethyl)-10-(hydroxymethyl)-5,8,13-trioxo-22-oxa-6,9,14,20,21-pentaazabicyclo[17.2.1]docosa-1(21),19-dien-4-yl]carbamate | Formula: | C29 H48 N6 O7 | Definition date: | 2020-08-12 | Last modified: | 2020-08-12 |
|
![PRD_002250 PRD_002250](https://data.pdbj.org/pdbjplus/data/cc/svg/7C7.svg) | PRD_002250 | Name: | N,N-diethyl-N~2~-(3-phenylpropanoyl)-L-asparaginyl-O-methyl-N-[(naphthalen-1-yl)methyl]-L-serinamide | Formula: | C32 H40 N4 O5 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
![PRD_002252 PRD_002252](https://data.pdbj.org/pdbjplus/data/cc/svg/7HJ.svg) | PRD_002252 | Name: | N,N-diethyl-N~2~-[(2E)-3-phenylprop-2-enoyl]-L-asparaginyl-4-fluoro-N-[(naphthalen-1-yl)methyl]-L-phenylalaninamide | Formula: | C37 H39 F N4 O4 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
![PRD_002255 PRD_002255](https://data.pdbj.org/pdbjplus/data/cc/svg/7HY.svg) | PRD_002255 | Name: | N,N-diethyl-N~2~-(3-phenylpropanoyl)-L-asparaginyl-N-[(naphthalen-1-yl)methyl]-L-alaninamide | Formula: | C31 H38 N4 O4 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
![PRD_002272 PRD_002272](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002272.svg) | PRD_002272 | Name: | (3R)-3,6-diamino-N-({(2R,5R,8Z,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-5-yl}methyl)hexanamide | Formula: | C25 H44 N14 O7 | Definition date: | 2020-08-12 | Last modified: | 2020-08-12 |
|
![PRD_002289 PRD_002289](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002289.svg) | PRD_002289 | Name: | 3-[(3R,6S,9S,12S,15S,18S,21S,24R,27S)-21-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,24,27-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29-decaoxo-12-(propan-2-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29-octacosahydro-1H-1,4,7,10,13,16,19,22,25,28-benzodecaazacyclohentriacontin-18-yl]propanamide | Formula: | C68 H85 N13 O13 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
![PRD_002290 PRD_002290](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002290.svg) | PRD_002290 | Name: | 4-[(3R,6S,9S,12S,15S,18S,21S,24R,27S)-21-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,24,27-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29-decaoxo-12-(propan-2-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29-octacosahydro-1H-1,4,7,10,13,16,19,22,25,28-benzodecaazacyclohentriacontin-18-yl]butan-1-aminium | Formula: | C69 H90 N13 O12 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
![PRD_002295 PRD_002295](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002295.svg) | PRD_002295 | Formula: | C89 H131 N23 O25 S3 | Definition date: | 2020-08-12 | Last modified: | 2020-08-12 |
|
![PRD_000734 PRD_000734](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000734.svg) | PRD_000734 | Name: | ALL-D KALATA B1 | Formula: | C117 H180 N35 O39 S6 | Definition date: | 2020-08-12 | Last modified: | 2023-09-20 |
|
![PRD_000749 PRD_000749](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000749.svg) | PRD_000749 | Name: | KALATA B1 | Formula: | C117 H180 N35 O39 S6 | Definition date: | 2020-08-12 | Last modified: | 2023-09-20 |
|
![PRD_000752 PRD_000752](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000752.svg) | PRD_000752 | Name: | CIRCULIN A | Formula: | C134 H211 N38 O38 S6 | Definition date: | 2020-08-12 | Last modified: | 2023-09-20 |
|
![PRD_002363 PRD_002363](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002363.svg) | PRD_002363 | Formula: | C73 H120 N20 O13 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
![PRD_002365 PRD_002365](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002365.svg) | PRD_002365 | Name: | phazolicin | Formula: | C74 H104 N29 O27 S3 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
![PRD_900129 PRD_900129](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900129.svg) | PRD_900129 | Name: | Lewis A antigen, beta anomer | Formula: | C20 H35 N O15 | Description: | oligosaccharide with branches | Definition date: | 2020-08-05 | Last modified: | 2020-08-05 |
|
![PRD_900130 PRD_900130](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900130.svg) | PRD_900130 | Name: | Lewis A antigen, alpha anomer | Formula: | C20 H35 N O15 | Description: | oligosaccharide with branches | Definition date: | 2020-08-05 | Last modified: | 2020-08-05 |
|
![PRD_900131 PRD_900131](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900131.svg) | PRD_900131 | Name: | Blood group A H type 1 antigen, beta anomer | Formula: | C28 H48 N2 O20 | Description: | oligosaccharide with branches | Definition date: | 2020-08-05 | Last modified: | 2020-08-05 |
|
![PRD_900132 PRD_900132](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900132.svg) | PRD_900132 | Name: | Blood group A H type 2 antigen, beta anomer | Formula: | C28 H48 N2 O20 | Description: | oligosaccharide with branches | Definition date: | 2020-08-05 | Last modified: | 2020-08-05 |
|
![PRD_900133 PRD_900133](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900133.svg) | PRD_900133 | Name: | Blood group A H type 2 antigen, alpha anomer | Formula: | C28 H48 N2 O20 | Description: | oligosaccharide with branches | Definition date: | 2020-08-05 | Last modified: | 2020-08-05 |
|
![PRD_900001 PRD_900001](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900001.svg) | PRD_900001 | Name: | MALTOSE | Formula: | C12 H22 O11 | Description: | oligosaccharide | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
![PRD_900002 PRD_900002](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900002.svg) | PRD_900002 | Name: | raffinose | Formula: | C18 H32 O16 | Description: | oligosaccharide with reducing-end-to-reducing-end glycosidic bond | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|